Bronchopulmonary dysplasia (BPD) is the most common chronic lung disease in infants and
is associated with increased mortality, respiratory morbidity, neurodevelopmental …

Background: Very preterm birth often results in the development of bronchopulmonary
dysplasia (BPD) with an inverse correlation of gestational age and birthweight. This very …

Background Aerosol drug delivery during high flow nasal oxygen (HFNO) and invasive
mechanical ventilation (IMV) are key respiratory care strategies available for the treatment of …

Background The effectiveness of nitric oxide (NO) in reducing the risk of bronchopulmonary
dysplasia (BPD) remains debatable. In this study, we performed a meta-analysis to guide …

Bronchopulmonary dysplasia (BPD) is a disease of complex and multifactorial etiology and
a major cause of morbidity in premature infants. Contributing factors include infection …

Delivering aerosolised drugs to infants poses a number of challenges. It is clear that drug
delivery is possible via the inhaled route but to date it has been difficult to demonstrate …

Objective To systematically review: 1) peri-extubation settings; and 2) association between
peri-extubation settings and outcomes in preterm neonates. Study Design In this systematic …

The inhaled route for drug administration in neonates offers several advantages over the
systemic routes, since it delivers medications directly to the diseased organ, enabling higher …

Bronchopulmonary dysplasia (BPD) is a common morbidity affecting preterm infants and is
associated with substantial long-term disabilities. The pathogenesis of BPD is multifactorial …

Background Bronchodilator responses among preterm infants are heterogeneous. Bedside
measurements may identify responders. Study design Respiratory measurements …